Scarica l'app Stockscreener
39.73
0.51%
0.2833
Precedente Chiudi:
$39.45
Aprire:
$39.46
Volume 24 ore:
9,910
Relative Volume:
0.01
Capitalizzazione di mercato:
$4.19B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-9.33%
1M Prestazione:
+36.73%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$37.43
$39.99
Intervallo di 1 settimana:
$37.00
$47.40
Portata 52W:
$12.30
$47.40
Metsera Inc Stock (MTSR) Company Profile
Nome
Metsera Inc
Settore
Industria
Telefono
(212) 784-6595
Indirizzo
3 WORLD TRADE CENTER, NEW YORK
Confronta MTSR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
39.88 | 4.52B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.49 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.38 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.29 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.24 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-20 | Iniziato | Wells Fargo | Overweight |
| 2025-02-25 | Iniziato | BofA Securities | Buy |
| 2025-02-25 | Iniziato | Evercore ISI | Outperform |
| 2025-02-25 | Iniziato | Guggenheim | Buy |
Metsera Inc Borsa (MTSR) Ultime notizie
Metsera Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com
What drives Metsera Inc. stock priceFree Advanced Stock Screener Access - jammulinksnews.com
What analysts say about Metsera Inc. stockFree Consultation - jammulinksnews.com
Is Metsera Inc. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com
Metsera price target raised to $45 from $38 at BofA - TipRanks
Metsera, Inc.: Buy Rating Affirmed Amid Promising Clinical Data and Strategic Positioning - TipRanks
ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews
Metsera soars 75% after InvestingPro’s April undervalued signal By Investing.com - Investing.com Nigeria
Metsera (MTSR) Presented at the 85th Scientific Sessions of the American Diabetes Association - MSN
Why Metsera Inc. stock attracts strong analyst attentionFast Gains With Reduced Risk - Newser
What makes Metsera Inc. stock price move sharplyLow Risk Profit Ideas - Newser
How Metsera Inc. stock performs during market volatility2x Return Forecast - Newser
Metsera Inc. (MTSR) Is a Great Choice for 'Trend' Investors, Here's Why - sharewise.com
Wall Street Analysts See a 55.72% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - Yahoo Finance
Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - Yahoo Finance
Metsera, Inc.(NasdaqGS: MTSR) added to S&P Biotechnology Select Industry Index - MarketScreener
Metsera (NASDAQ:MTSR) Now Covered by Analysts at Wells Fargo & Company - Defense World
Metsera stock initiated at overweight by Wells Fargo on obesity drug - Investing.com Nigeria
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results - MSN
Cantor Fitzgerald reiterates Metsera stock rating on strong MET-233i results - Investing.com Nigeria
Promising Results Of Amylin Analogs In Obesity: Metsera Case Review (NASDAQ:MTSR) - Seeking Alpha
Cantor Fitzgerald Predicts Metsera FY2026 Earnings - Defense World
13 Biotech Stocks with Huge Upside Potential - Insider Monkey
Metsera Shows Rising Price Performance With Jump To 92 RS Rating - MSN
Metsera Inc Azioni (MTSR) Dati Finanziari
Non sono disponibili dati finanziari per Metsera Inc (MTSR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Metsera Inc Azioni (MTSR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Feb 03 '25 |
Buy |
18.00 |
789,998 |
14,219,964 |
8,313,680 |
| ARCH Venture Partners XII, LLC | 10% Owner |
Feb 03 '25 |
Buy |
18.00 |
2,222,222 |
39,999,996 |
18,503,128 |
4.55%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):